Literature DB >> 17063178

Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction.

B Friedrich1, D Alexander, A Janessa, H-U Häring, F Lang, T Risler.   

Abstract

Chronic microinflammation increases cardiovascular morbidity in chronic hemodialysis (HD) patients. Previously published studies are controversial with respect to acute effects of HD treatment on up- or downregulation of cytokine protein levels. Twenty-nine chronic HD patients were hemodialysed for 4 h with a 4008 dialyser using high-flux membranes. Patients were separated into a low (up to 1 mg/dl) and a high (1.1 to 5.5 mg/dl) C-reactive protein (CRP) group. Blood was drawn before HD and 240 min after initiation of HD. Acute changes of transcript levels encoding pro- and anti-inflammatory mediators were analyzed in RNA stabilized immediately from blood leukocytes using microarray analysis (n=1) and quantitative real-time polymerase chain reaction (PCR) (Light Cycler) (n=29). In both patient groups, HD treatment significantly increased the transcript levels of several pro-inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-8 (IL-8), and chemokine receptors such as C-X-C chemokine receptor type 4, C-C chemokine receptor type 7, and the fractakine receptor CX3C chemokine receptor 1. In the low CRP group, the increase of transcript levels for anti-inflammatory IL-1-receptor antagonist and of the receptor for the anti-inflammatory cytokines IL-10 and interferon gamma was significantly more pronounced than in the high CRP group. Subgroup analysis revealed no difference between diabetic vs non-diabetic patients. These observations point towards a marked influence of a routine hemodialysis treatment on transcription in leukocytes of pro- and anti-inflammatory cytokines and receptors relevant for microinflammation. Diminished upregulation of receptors for anti-inflammatory factors in HD patients with high CRP levels could contribute to enhanced microinflammation in those patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17063178     DOI: 10.1038/sj.ki.5001865

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

Review 1.  Hemodialysis-induced cardiovascular disease.

Authors:  Shadi Ahmadmehrabi; W H Wilson Tang
Journal:  Semin Dial       Date:  2018-04-06       Impact factor: 3.455

Review 2.  Does inflammation affect outcomes in dialysis patients?

Authors:  Kristen L Nowak; Michel Chonchol
Journal:  Semin Dial       Date:  2018-03-07       Impact factor: 3.455

3.  Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis.

Authors:  Ioannis Kourtzelis; Maciej M Markiewski; Michael Doumas; Stavros Rafail; Konstantinos Kambas; Ioannis Mitroulis; Stelios Panagoutsos; Ploumis Passadakis; Vasilios Vargemezis; Paola Magotti; Hongchang Qu; Tom Eirik Mollnes; Konstantinos Ritis; John D Lambris
Journal:  Blood       Date:  2010-04-27       Impact factor: 22.113

4.  Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.

Authors:  Jorge L Gamboa; Mias Pretorius; Deanna R Todd-Tzanetos; James M Luther; Chang Yu; T Alp Ikizler; Nancy J Brown
Journal:  J Am Soc Nephrol       Date:  2011-12-08       Impact factor: 10.121

Review 5.  Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.

Authors:  G Zaza; S Granata; F Sallustio; G Grandaliano; F P Schena
Journal:  Clin Exp Immunol       Date:  2009-11-24       Impact factor: 4.330

6.  Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis.

Authors:  Annis M Marney; Ji Ma; James M Luther; T Alp Ikizler; Nancy J Brown
Journal:  J Am Soc Nephrol       Date:  2009-07-23       Impact factor: 10.121

7.  CCR5 deletion protects against inflammation-associated mortality in dialysis patients.

Authors:  Friso L H Muntinghe; Marion Verduijn; Mike W Zuurman; Diana C Grootendorst; Juan Jesus Carrero; Abdul Rashid Qureshi; Karin Luttropp; Louise Nordfors; Bengt Lindholm; Vincent Brandenburg; Martin Schalling; Peter Stenvinkel; Elisabeth W Boeschoten; Raymond T Krediet; Gerjan Navis; Friedo W Dekker
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

8.  Fine-tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determination.

Authors:  Stéphanie Badiou; Jean-Paul Cristol; Isabelle Jaussent; Nathalie Terrier; Marion Morena; François Maurice; Hélène Leray-Moragues; Jean-Pierre Rivory; Lofti Chalabi; Cécile Delcourt; Bernard Canaud; Anne-Marie Dupuy
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

Review 9.  Ultrafiltration in critically ill patients treated with kidney replacement therapy.

Authors:  Raghavan Murugan; Rinaldo Bellomo; Paul M Palevsky; John A Kellum
Journal:  Nat Rev Nephrol       Date:  2020-11-11       Impact factor: 28.314

10.  Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease.

Authors:  Simona Granata; Gianluigi Zaza; Simona Simone; Gaetano Villani; Dominga Latorre; Paola Pontrelli; Massimo Carella; Francesco Paolo Schena; Giuseppe Grandaliano; Giovanni Pertosa
Journal:  BMC Genomics       Date:  2009-08-21       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.